HighTower Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-29,918
Closed -$413K 3433
2024
Q1
$413K Buy
+29,918
New +$413K ﹤0.01% 2409
2023
Q4
Sell
-2,869
Closed -$13K 3429
2023
Q3
$13K Sell
2,869
-740
-21% -$3.35K ﹤0.01% 3274
2023
Q2
$17K Buy
3,609
+18
+0.5% +$85 ﹤0.01% 3195
2023
Q1
$35K Buy
3,591
+765
+27% +$7.46K ﹤0.01% 3025
2022
Q4
$51K Sell
2,826
-114
-4% -$2.06K ﹤0.01% 2980
2022
Q3
$60K Buy
2,940
+1
+0% +$20 ﹤0.01% 2809
2022
Q2
$60K Sell
2,939
-50
-2% -$1.02K ﹤0.01% 2842
2022
Q1
$127K Sell
2,989
-82
-3% -$3.48K ﹤0.01% 2908
2021
Q4
$180K Sell
3,071
-2
-0.1% -$117 ﹤0.01% 2785
2021
Q3
$265K Buy
3,073
+69
+2% +$5.95K ﹤0.01% 2492
2021
Q2
$335K Buy
3,004
+32
+1% +$3.57K ﹤0.01% 2292
2021
Q1
$331K Buy
2,972
+43
+1% +$4.79K ﹤0.01% 2223
2020
Q4
$310K Buy
2,929
+54
+2% +$5.72K ﹤0.01% 1882
2020
Q3
$401K Sell
2,875
-1,084
-27% -$151K ﹤0.01% 1662
2020
Q2
$1.28M Buy
3,959
+425
+12% +$137K 0.01% 1004
2020
Q1
$315K Sell
3,534
-779
-18% -$69.4K ﹤0.01% 1517
2019
Q4
$169K Sell
4,313
-3,413
-44% -$134K ﹤0.01% 1996
2019
Q3
$185K Sell
7,726
-51
-0.7% -$1.22K ﹤0.01% 2066
2019
Q2
$279K Buy
7,777
+14
+0.2% +$502 ﹤0.01% 1834
2019
Q1
$349K Buy
7,763
+54
+0.7% +$2.43K ﹤0.01% 1649
2018
Q4
$371K Sell
7,709
-1,083
-12% -$52.1K ﹤0.01% 1502
2018
Q3
$588K Buy
8,792
+769
+10% +$51.4K ﹤0.01% 1384
2018
Q2
$383K Buy
8,023
+6
+0.1% +$286 ﹤0.01% 1570
2018
Q1
$456K Sell
8,017
-144
-2% -$8.19K ﹤0.01% 1463
2017
Q4
$406K Buy
8,161
+1,015
+14% +$50.5K ﹤0.01% 1543
2017
Q3
$538K Buy
7,146
+3,926
+122% +$296K ﹤0.01% 1396
2017
Q2
$307K Buy
3,220
+1,917
+147% +$183K ﹤0.01% 1606
2017
Q1
$101K Hold
1,303
﹤0.01% 1862
2016
Q4
$103K Buy
+1,303
New +$103K ﹤0.01% 1768
2014
Q3
Sell
-909
Closed -$118K 1577
2014
Q2
$118K Buy
909
+8
+0.9% +$1.04K ﹤0.01% 1448
2014
Q1
$144K Buy
+901
New +$144K ﹤0.01% 1345